Coronavirus vaccine update: Bharat Biotech starts human trials; Russia successfully completes human testing

Coronavirus vaccine update: Bharat Biotech starts human trials; Russia successfully completes human testing

Bharat Biotech is developing the vaccine in collaboration with the ICMR. It has started human trials on its vaccine candidate, 'Covaxin', which is India's first indigenous COVID-19 vaccine. It is working to develop an initial capacity of 200 million vials of the vaccine

The WHO and its alliance partners, including the vaccine alliance GAVI, have said the goal is to create 2 billion doses of coronavirus vaccine by 2021.